RÉSUMÉ
Childhood asthma, a common chronic childhood disease, leads to high mortality and morbidity in the world. Airway smooth muscle cells (ASMCs) is a group of multifunctional cells that has been found to be correlated with the pathogenesis of asthma. Astragaloside IV (AS-IV) is a compound extracted from Astragalus membranaceus, which has the anti-asthmatic effect. However, the role of molecular mechanisms regulated by AS-IV in the biological processes of ASMCs in asthma remains unclear. Our current study aims to investigate the downstream molecular mechanism of AS-IV in modulating the aberrant proliferation and pyroptosis of ASMCs in asthma. At first, we determined that the viability of ASMCs could be efficiently suppressed by AS-IV treatment (200 µM). Moreover, AS-IV promoted the pyroptosis and suppressed PDGF-BB-induced aberrant proliferation. Through mechanism investigation, we confirmed that AS-IV could suppress high mobility group box 1 (HMGB1) expression and prevent it from entering the cytoplasm. Subsequently, AS-IV blocked the interaction between HMGB1 and advanced glycosylation end product-specific receptor (RAGE) to inactivate NF-κB pathway. Finally, in vivo experiments demonstrated that AS-IV treatment can alleviate the lung inflammation in asthma mice. Collectively, AS-IV alleviates asthma and suppresses the pyroptosis of AMSCs through blocking HMGB1/RAGE axis to inactivate NF-κB pathway.
Sujet(s)
Asthme , Protéine HMGB1 , Myocytes du muscle lisse , Facteur de transcription NF-kappa B , Pyroptose , Récepteur spécifique des produits finaux de glycosylation avancée , Saponines , Transduction du signal , Triterpènes , Saponines/pharmacologie , Pyroptose/effets des médicaments et des substances chimiques , Protéine HMGB1/métabolisme , Animaux , Souris , Myocytes du muscle lisse/métabolisme , Myocytes du muscle lisse/effets des médicaments et des substances chimiques , Facteur de transcription NF-kappa B/métabolisme , Asthme/traitement médicamenteux , Asthme/métabolisme , Asthme/anatomopathologie , Triterpènes/pharmacologie , Récepteur spécifique des produits finaux de glycosylation avancée/métabolisme , Transduction du signal/effets des médicaments et des substances chimiques , Humains , Modèles animaux de maladie humaineRÉSUMÉ
Aluminum (Al) exposure inhibits bone formation. Osteoblastic proliferation promotes bone formation. Therefore, we inferred that Al may inhibit bone formation by the inhibition of osteoblastic proliferation. However, the effects and molecular mechanisms of Al on osteoblastic proliferation are still under investigation. Osteoblastic proliferation can be regulated by Wnt/ß-catenin signaling pathway. To investigate the effects of Al on osteoblastic proliferation and whether Wnt/ß-catenin signaling pathway is involved in it, osteoblasts from neonatal rats were cultured and exposed to 0, 0.4 mM (1/20 IC50), 0.8 mM (1/10 IC50), and 1.6 mM (1/5 IC50) of aluminum trichloride (AlCl3) for 24 h, respectively. The osteoblastic proliferation rates; Wnt3a, lipoprotein receptor-related protein 5 (LRP-5), T cell factor 1 (TCF-1), cyclin D1, and c-Myc messenger RNA (mRNA) expressions; and p-glycogen synthase kinase 3ß (GSK3ß), GSK3ß, and ß-catenin protein expressions indicated that AlCl3 inhibited osteoblastic proliferation and downregulated Wnt/ß-catenin signaling pathway. In addition, the AlCl3 concentration was negatively correlated with osteoblastic proliferation rates and the mRNA expressions of Wnt3a, c-Myc, and cyclin D1, while the osteoblastic proliferation rates were positively correlated with mRNA expressions of Wnt3a, c-Myc, and cyclin D1. Taken together, these findings indicated that AlCl3 inhibits osteoblastic proliferation may be associated with the inactivation of Wnt/ß-catenin signaling pathway.
Sujet(s)
Composés de l'aluminium/toxicité , Chlorures/toxicité , Régulation négative/effets des médicaments et des substances chimiques , Ostéoblastes/effets des médicaments et des substances chimiques , Voie de signalisation Wnt/effets des médicaments et des substances chimiques , bêta-Caténine/antagonistes et inhibiteurs , Chlorure d'aluminium , Animaux , Prolifération cellulaire/effets des médicaments et des substances chimiques , Cellules cultivées , Relation dose-effet des médicaments , Ostéoblastes/anatomopathologie , Rats , Rat Sprague-Dawley , Relation structure-activité , bêta-Caténine/métabolismeRÉSUMÉ
Aluminum (Al) exposure impairs bone formation, and bone formation is mediated by the osteoblasts. But effects of Al on the osteoblasts function remain elusive. The osteoblasts were exposed to 0, 0.0252, 0.126, 0.252mg/mL AlCl3·6H2O for 24h. The osteoblasts viability, TGF-ß1, BMP-2, IGF-I and Cbfα1 mRNA expressions, and GSH-Px and SOD activities, ROS concentration were determined. The osteoblasts ultrastructural features were also observed. The results showed that AlCl3 suppressed the osteoblasts viability, TGF-ß1, BMP-2, IGF-I and Cbfα1 mRNA expressions, GSH-Px and SOD activities, and elevated ROS concentration compared with the CG. The ultrastructural features of osteoblasts in the HG showed mitochondrial swelling, foam-like structure, uneven distribution of chromatin, incomplete cell membrane and cytoplasm spillover compared with the CG. It indicates that AlCl3 inhibits osteoblasts viability, growth regulation factors mRNA expressions, anti-oxidative function, and damaged the osteoblasts histology structure, impairing the osteoblasts function.
Sujet(s)
Composés de l'aluminium/toxicité , Chlorures/toxicité , Ostéoblastes/effets des médicaments et des substances chimiques , Chlorure d'aluminium , Animaux , Animaux nouveau-nés , Antioxydants/métabolisme , Protéine morphogénétique osseuse de type 2/génétique , Protéine morphogénétique osseuse de type 2/métabolisme , Survie cellulaire/effets des médicaments et des substances chimiques , Cellules cultivées , Relation dose-effet des médicaments , Facteur de croissance IGF-I/génétique , Facteur de croissance IGF-I/métabolisme , Gonflement mitochondrial/effets des médicaments et des substances chimiques , Ostéoblastes/métabolisme , Ostéoblastes/ultrastructure , ARN messager/génétique , ARN messager/métabolisme , Rat Wistar , Espèces réactives de l'oxygène/métabolisme , Facteur de croissance transformant bêta-1/génétique , Facteur de croissance transformant bêta-1/métabolismeRÉSUMÉ
Osteoblasts dysfunction, induced by aluminum (Al), plays a critical role in the osteoporosis etiology. Ginsenoside Rb1 (Rb1) has the therapeutic properties for osteoporosis. This study aimed to assess the efficiency of Rb1 in ameliorating Al-induced osteoblasts dysfunction. The osteoblasts were divided into four groups: Rb1-treated group (RG, 0.0145mg/mL Rb1), control group (CG, 0), AlCl3-treated group (AG, 0.126mg/mL AlCl3·6H2O), AlCl3+Rb1-treated group (ARG, 0.0145mg/mL Rb1 and 0.126mg/mL AlCl3·6H2O). After 24h of culture, the osteoblasts viability, the transforming growth factor-ß1 (TGF-ß1), bone morphogenetic protein-2 (BMP-2), the insulin-like growth factor I (IGF-I), core-binding factor α1 (Cbfα1) mRNA expressions, glutathione perioxidase (GSH-Px) and superoxide dismutase (SOD) activities, and reactive oxygen species (ROS) concentration were determined. The osteoblasts ultrastructural features were also observed. In the ARG, the osteoblasts viability, TGF-ß1, BMP-2, IGF-I and Cbfα1 mRNA expressions and the GSH-Px and SOD activities were significantly increased, the ROS concentration was significantly decreased, and osteoblasts histology lesion was attenuated compared with the AG. These results demonstrated that Rb1 could significantly reverse osteoblasts viability and osteoblasts growth regulation factor, inhibit oxidative stress, and attenuate histology lesion in the osteoblasts with AlCl3. These results indicate that Rb1 can effectively alleviate the AlCl3-induced osteoblasts dysfunction.
Sujet(s)
Composés de l'aluminium/toxicité , Chlorures/toxicité , Ginsénosides/pharmacologie , Ostéoblastes/effets des médicaments et des substances chimiques , Chlorure d'aluminium , Animaux , Protéine morphogénétique osseuse de type 2/génétique , Protéine morphogénétique osseuse de type 2/métabolisme , Survie cellulaire/effets des médicaments et des substances chimiques , Sous-unité alpha 1 du facteur CBF/génétique , Sous-unité alpha 1 du facteur CBF/métabolisme , Modèles animaux de maladie humaine , Glutathione peroxidase/génétique , Glutathione peroxidase/métabolisme , Facteur de croissance IGF-I/génétique , Facteur de croissance IGF-I/métabolisme , Ostéoblastes/métabolisme , Ostéoporose/induit chimiquement , Ostéoporose/traitement médicamenteux , Stress oxydatif/effets des médicaments et des substances chimiques , ARN messager/génétique , ARN messager/métabolisme , Rats , Rat Wistar , Espèces réactives de l'oxygène/métabolisme , Superoxide dismutase/génétique , Superoxide dismutase/métabolisme , Facteur de croissance transformant bêta-1/génétique , Facteur de croissance transformant bêta-1/métabolismeRÉSUMÉ
N-Acetyl-ß-D-glucosaminidase (NAGase) is proved to be correlated with reproduction of male animals. In this study, enzymatic characterizations of NAGase from spermary of Nile tilapia (Oreochromis niloticus) were investigated in order to further study its reproductive function in fish. Tilapia NAGase was purified to be PAGE homogeneous by the following techniques: (NH4)2SO4 fractionation (40-55%), DEAE-cellulose (DE-32) ion exchange chromatography, Sephadex G-200 gel filtration and DEAE-Sephadex (A-50). The specific activity of the purified enzyme was 4100 U/mg. The enzyme molecular weight was estimated as 118.0 kD. Kinetic studies showed that the hydrolysis of p-nitrophenyl-N-acetyl-ß-D-glucosaminide (pNP-NAG) by the enzyme followed Michaelis-Menten kinetics. The Michaelis-Menten constant (Km) and maximum velocity (Vm) were determined to be 0.67 mM and 23.26 µM/min, respectively. The optimum pH and optimum temperature of the enzyme for hydrolysis of pNP-NAG was to be at pH 5.7 and 55°C, respectively. The enzyme was stable in a pH range from 3.3 to 8.1 at 37°C, and inactive at temperature above 45°C. The enzyme activity was regulated by the following ions in decreasing order: Hg(2+) > Zn(2+) > Cu(2+) > Pb(2+) > Mn(2+). The IC50 of Cu(2+), Zn(2+) and Hg(2+) was 1.23, 0.28, and 0.0027 mM, respectively. However, the ions Li(+), Na(+), K(+), Mg(2+) and Ca(2+) had almost no influence on enzyme activity. In conclusion, the enzymatic characterizations of NAGase from tilapia were special to the other animals, which were correlated with its living habit; besides, CuSO4 and ZnSO4 should used very carefully as insecticides in tilapia cultivation since they both had strong regulations on the enzyme.
Sujet(s)
Acetylglucosaminidase/métabolisme , Cichlides , Acetylglucosaminidase/composition chimique , Acetylglucosaminidase/isolement et purification , Animaux , Stabilité enzymatique , Concentration en ions d'hydrogène , Hydrolyse/effets des médicaments et des substances chimiques , Cinétique , Mâle , Métaux/pharmacologie , Masse moléculaire , TempératureRÉSUMÉ
Norepinephrine (NE) regulates the splenic immune function and it may be related to the effects of Aluminum (Al) on the splenic immune function. Here, the aim of this study was to further explore the effects of aluminum trichloride (AlCl3) on the splenic immune function and its relationship with NE. Forty male Wistar rats were orally exposed to AlCl3 (0, 64.18, 128.36 and 256.72 mg/kg BW) through drinking water for 120 days. The CD3(+), CD4(+), CD8(+) T lymphocytes, the T and B lymphocytes proliferation rates and serum NE concentration were examined. The correlation analysis between splenic immune function and NE were done. The results showed that the CD3(+), CD4(+), CD8(+) T lymphocytes and the T and B lymphocytes proliferation rates decreased and NE concentration increased in AlCl3-treated rats. NE was negatively correlated with proportions of CD3(+), CD4(+) T lymphocytes and T and B lymphocytes proliferation rates, but not correlated with CD8(+) T lymphocytes. The results suggest that AlCl3 suppresses the splenic immune function and NE plays important role in this process.
Sujet(s)
Aluminium/toxicité , Norépinéphrine/métabolisme , Rate/effets des médicaments et des substances chimiques , Rate/immunologie , Chlorure d'aluminium , Composés de l'aluminium/toxicité , Animaux , Lymphocytes B/effets des médicaments et des substances chimiques , Poids/effets des médicaments et des substances chimiques , Antigènes CD3 , Lymphocytes T CD4+/effets des médicaments et des substances chimiques , Lymphocytes T CD8+/effets des médicaments et des substances chimiques , Prolifération cellulaire/effets des médicaments et des substances chimiques , Chlorures/toxicité , Mâle , Norépinéphrine/sang , Rat WistarRÉSUMÉ
The aim of this study was to investigate the effect of norepinephrine (NE) on spleen lymphocytes exposed to aluminum trichloride (AlCl3). In this experiment, lymphocytes were isolated from spleens of healthy Wistar rats weighing about 130 g and cultured with RPMI-1640 medium containing the final concentration of 0.552 mmol/L AlCl3. NE was added to the cultured cells at the final concentrations of 0 (control group), 0.1 (low-dose group), 1 (mid-dose group), and 10 (high-dose group) nmol/L. No addition of both AlCl3 and NE serviced as blank (BG). The T lymphocyte proliferation; the contents of IL-2, TNF-α, and T lymphocyte subsets; immunoglobulin G (IgG) and intracellular cyclic adenosine monophosphate (cAMP) concentrations; and ß2-adrenergic receptor (ß2-AR) density were measured at the end of the culture. The result showed that NE decreased T lymphocyte proliferation and the contents of IL-2, TNF-α, and T lymphocyte subsets whereas increased the concentrations of IgG and intracellular cAMP and ß2-AR density of the lymphocyte exposed to AlCl3. AlCl3 exposure without adding NE showed the similar impacts on these measures compared with BG. The results suggested that NE aggravated AlCl3 immunotoxicity on the lymphocytes and disordered the immune functions of the lymphocyte through the ß2-AR-cAMP signal pathway.
Sujet(s)
Agonistes alpha-adrénergiques/pharmacologie , Composés de l'aluminium/pharmacologie , Astringents/pharmacologie , Prolifération cellulaire/effets des médicaments et des substances chimiques , Chlorures/pharmacologie , Norépinéphrine/pharmacologie , Lymphocytes T/immunologie , Chlorure d'aluminium , Animaux , Cellules cultivées , AMP cyclique/immunologie , Relation dose-effet des médicaments , Interleukine-2/immunologie , Rats , Rat Wistar , Récepteurs bêta-2 adrénergiques/immunologie , Systèmes de seconds messagers/effets des médicaments et des substances chimiques , Systèmes de seconds messagers/immunologie , Rate , Lymphocytes T/cytologie , Facteur de nécrose tumorale alpha/immunologieRÉSUMÉ
Aluminum (Al) is a low toxicological metal and can accumulate in the liver. The hepatic microsomal cytochrome P450 enzyme system (CYPS) plays important role in the transformation of the toxic materials. It is not clear if the CYPS is affected by Al exposure. Thus, the aim of this study is to investigate the effects of aluminum trichloride (AlCl(3)) on CYPS in rats. Forty male Wistar rats (5weeks old) weighing 110-120g were randomly allocated and orally exposed to 0, 64.18, 128.36 and 256.72mg/kg body weight (BW) AlCl(3) in drinking water for 120days. The body weight (BW) of rats, hepatosomatic index (HSI), hepatic Al content, the concentrations of cytochrome P450 (CYP450), cytochrome B5 (B5), microsomal protein and the activities of NADPH-cytochrome c reductase (CR), aminopyrin N-demethylase (AND), erythromycin N-demethylase (ERND) and aniline-4-hydeoxylase (AH) were assessed at the end of the experiment. The results showed that the increase in Al concentration decreased BW, HIS, concentrations of CYP450, B5, microsomal protein and the activity of CR, AND, ERND and AH in hepatic microsomes. The results revealed that exposure to AlCl(3) inhibited the microsomal CYP450 dependent enzyme system of liver. Our findings suggest that long term daily exposure of AlCl(3) exerts the suppressive effects and thus may cause dysfunction of hepatic CYP450 dependent enzyme system of rat.
Sujet(s)
Composés de l'aluminium/toxicité , Chlorures/toxicité , Cytochrome P-450 enzyme system/métabolisme , Foie/effets des médicaments et des substances chimiques , Foie/métabolisme , Chlorure d'aluminium , Animaux , Poids/effets des médicaments et des substances chimiques , Cytochromes b5/métabolisme , Eau de boisson/composition chimique , Polluants environnementaux/toxicité , Mâle , Microsomes du foie/effets des médicaments et des substances chimiques , Microsomes du foie/métabolisme , Rats , Rat WistarRÉSUMÉ
The bioaccumulation and immunotoxicity of aluminum (Al) have been previously documented. Al accumulates in the organs of the organism, including spleen. Spleen is a peripheral organ of the immune system. The accumulated Al may alter the immune function. Here, we investigated the bioaccumulation of Al in spleen and its alterations in the immune system. Forty male Wistar rats (5 weeks old) weighed 110-120 g were orally exposed to aluminum trichloride (AlCl(3)) (0, 64.18, 128.36 and 256.72 mg/kg body weight) in drinking water for 120 days. The concentrations of spleen's Al, iron (Fe), copper (Cu), zinc (Zn), interleukin-2 (IL-2), tumor necrosis factor-α (TNF-α) and growth index were examined at the end of the experiment. The results showed that the concentrations of Al and Cu in the spleen were increased in an AlCl(3)-dose dependent manner, and the concentrations of spleen's growth index, Fe, Zn, IL-2 and TNF-α were reduced in AlCl(3)-treated rats. The results suggest that AlCl(3) can suppress the growth of spleen, disorder the balance of trace elements and inhibit the immune regulation of cytokines in the spleen. It indicates that AlCl(3) suppresses the immune function of spleen.
Sujet(s)
Composés de l'aluminium/pharmacologie , Chlorures/pharmacologie , Interleukine-2/métabolisme , Rate/effets des médicaments et des substances chimiques , Oligoéléments/métabolisme , Facteur de nécrose tumorale alpha/métabolisme , Chlorure d'aluminium , Animaux , Poids/effets des médicaments et des substances chimiques , Mâle , Rats , Rat Wistar , Rate/métabolismeRÉSUMÉ
The aim of this study was to investigate the effects of aluminum (Al) exposure on the reproductive function in female rats. Forty female Wistar (5 weeks old) rats, weighing 110-120 g, were divided randomly into four groups. They were orally administrated with 0, 64.18, 128.36, and 256.72 mg aluminum chloride (AlCl(3)) per kilogram body weight in drinking water for 120 days. Levels of Al, estrogen (E(2)), progestogen (P), testosterone (T), follicle-stimulating hormone (FSH), and luteinizing hormone (LH) in serum were measured at the end of experiment. The results showed that levels of E(2), P, FSH, and LH were significantly lower and Al concentration was significantly higher in all three Al-treated groups than those in the control group (GC). The level of T was significantly higher in the low- and medium-dose groups (GL and GM) (P < 0.05) but not in high-dose group (GH) compared with GC. The results suggest that the reproductive function of female rats is inhibited under long-term Al exposure in an Al dose-dependent manner.
Sujet(s)
Aluminium/pharmacologie , Reproduction/effets des médicaments et des substances chimiques , Aluminium/administration et posologie , Aluminium/sang , Aluminium/métabolisme , Animaux , Poids/effets des médicaments et des substances chimiques , Oestradiol/sang , Femelle , Hormone folliculostimulante/sang , Hormone lutéinisante/sang , Taille d'organe/effets des médicaments et des substances chimiques , Ovaire/effets des médicaments et des substances chimiques , Ovaire/métabolisme , Progestérone/sang , Rats , Rat Wistar , Testostérone/sang , Tests de toxicité subchroniqueRÉSUMÉ
Aluminum (Al) has increasingly been used in the daily life, and could cause the change of human health because it can accumulate in the organs. A rat model was thus used to examine potential effect of Al on the immune function. Forty male Wistar rats (5 weeks old) weighed 110-120 g were randomly allocated into four groups and were orally exposed to 0, 64.18, 128.36, and 256.72 mg/kg body weight aluminum trichloride (AlCl3) in drinking water for 120 days. The levels of CD3+, CD4+, CD8+ T lymphocyte, acid non-specific activity esterase (ANAE+) in blood, and interleukin-2 (IL-2) and tumor necrosis factor-α (TNF-α) in serum were determined at the end of experiment. The results showed that the proportions of CD3+, CD4+ T lymphocyte, the ratio of CD4+/CD8+, and the levels of ANAE+, IL-2, and TNF-α were significantly reduced in AlCl3-treated rats, while the proportion of CD8+ T lymphocyte was increased in an AlCl3-dose dependent manner. Our findings indicate that a long term exposure of AlCl3 could suppress the T lymphocyte immune function of rats.
Sujet(s)
Composés de l'aluminium/pharmacologie , Chlorures/pharmacologie , Lymphocytes T/effets des médicaments et des substances chimiques , Chlorure d'aluminium , Animaux , Rapport CD4-CD8 , Cytométrie en flux , Immunophénotypage , Mâle , Rats , Rat Wistar , Lymphocytes T/immunologieRÉSUMÉ
The effects of Aluminum (Al) exposure on immune functions of cultured splenic T and B lymphocytes of rats were studied. The lymphocytes were isolated from spleen of healthy male Wistar rats weighing 110-120 g. The cultured cells in RPMI-1640 medium were exposed to 0 (control group), 0.035 (low-dose group), 0.07 (medial-dose group), and 0.14 (high-dose group) mg/mL Al(3+) as aluminum trichloride (AlCl(3)) in an incubator under 5% CO(2) at 37°C for 24 h. The T and B lymphocyte proliferation was measured with a tetrazolium dye colorimetric assay. The levels of interleukin (IL)-2, IL-6, and tumor necrosis factor (TNF)-α were determined by iodine [(125)I] IL-2, IL-6, and TNF-α radioimmunoassay kits, respectively. The proportions of CD3(+), CD4(+), and CD8(+) T lymphocytes were measured with a flow cytometer. The results showed that the T and B lymphocyte proliferation, the levels of IL-2, IL-6, TNF-α, the proportions of CD3(+) and CD4(+) T lymphocytes, and the ratio of CD4(+)/CD8(+) T lymphocytes were lowered by Al treatments, while the proportion of CD8(+) T lymphocytes was increased. These findings indicate that Al exposure can inhibit the immune functions of splenic T and B lymphocytes of rats in vitro.
Sujet(s)
Aluminium/pharmacologie , Lymphocytes B/effets des médicaments et des substances chimiques , Prolifération cellulaire/effets des médicaments et des substances chimiques , Lymphocytes T/effets des médicaments et des substances chimiques , Chlorure d'aluminium , Composés de l'aluminium/pharmacologie , Animaux , Lymphocytes B/immunologie , Lymphocytes B/métabolisme , Antigènes CD3/immunologie , Antigènes CD3/métabolisme , Lymphocytes T CD4+/effets des médicaments et des substances chimiques , Lymphocytes T CD4+/immunologie , Lymphocytes T CD4+/métabolisme , Lymphocytes T CD8+/effets des médicaments et des substances chimiques , Lymphocytes T CD8+/immunologie , Lymphocytes T CD8+/métabolisme , Cellules cultivées , Chlorures/pharmacologie , Relation dose-effet des médicaments , Interleukine-2/immunologie , Interleukine-2/métabolisme , Interleukine-6/immunologie , Interleukine-6/métabolisme , Numération des lymphocytes , Mâle , Dosage radioimmunologique , Rats , Rat Wistar , Rate/cytologie , Rate/immunologie , Lymphocytes T/immunologie , Lymphocytes T/métabolisme , Facteur de nécrose tumorale alpha/immunologie , Facteur de nécrose tumorale alpha/métabolismeRÉSUMÉ
To investigate the effects of aluminum (Al) exposure on peritoneal macrophages of Wistar rats, four groups of ten rats each were orally exposed to 0, 13, 26, and 52 mg kg(-1) Al(3+) in form of aluminum trichloride (AlCl(3)) in drinking water for 120 days. At the end of the experimental period, the Al concentration in serum, the adherence, chemotaxis, and phagocytosis capacity of peritoneal macrophages were determined. The results showed that the Al concentration in serum significantly increased in a dose-dependent manner; the adherence, chemotaxis, and phagocytosis capacity of peritoneal macrophages decreased with the increase of Al dose, and present a dose-effective relationship. Further, they were significantly lower in the high-dose groups (P < 0.01) compared with the control group. It indicates that Al was toxic to peritoneal macrophages of rats, and the adherence, chemotaxis, and phagocytosis capacity of peritoneal macrophages in rats were significantly suppressed by exposure to 52 mg kg(-1) day Al(3+).
Sujet(s)
Aluminium/toxicité , Adhérence cellulaire/effets des médicaments et des substances chimiques , Chimiotaxie des leucocytes/effets des médicaments et des substances chimiques , Macrophages péritonéaux/effets des médicaments et des substances chimiques , Phagocytose/effets des médicaments et des substances chimiques , Aluminium/sang , Chlorure d'aluminium , Composés de l'aluminium/toxicité , Animaux , Chlorures/toxicité , Relation dose-effet des médicaments , Mâle , Rats , Rat WistarRÉSUMÉ
The effects of aluminum (Al) exposure on reproductive functions of male rats were investigated. Forty male Wistar rats (4 weeks old) weighing 75-95 g were randomly divided into four groups and orally exposed to 0 (control group GC), 64.18 (low-dose group GL), 128.36 (middle-dose group GM), and 256.72 (high-dose group GH) mg/kg aluminum trichloride in drinking water for 120 days. The levels of testosterone (T), follicle-stimulating hormone (FSH), and luteinizing hormone (LH) were determined by radioimmunoassay. The androgen receptor (AR) expressions in testes were detected respectively by immunohistochemistry and time quantitative PCR. Results showed that the levels of T and LH in GM and GH were lower than those in GC (P < 0.05), but there were no significant changes in FSH level in all Al-treated groups (P > 0.05). AR protein expressions in GM and GH were lower than those in GC (P < 0.05), and there was a dose-response relationship between Al-exposure doses and AR protein expressions. The levels of AR mRNA expressions were lower in all Al-treated groups than those of GC (P < 0.05). The results indicate that Al can cause endocrinal disorders and interfere with AR expression, which suppresses development and functional maintenance of the testes.
Sujet(s)
Aluminium/toxicité , Hormones sexuelles stéroïdiennes/biosynthèse , Récepteurs aux androgènes/biosynthèse , Algorithmes , Chlorure d'aluminium , Composés de l'aluminium/toxicité , Animaux , Chlorures/toxicité , Amorces ADN , Relation dose-effet des médicaments , Hormone folliculostimulante/sang , Immunohistochimie , Hormone lutéinisante/sang , Mâle , ARN messager/biosynthèse , ARN messager/génétique , Dosage radioimmunologique , Rats , Rat Wistar , Réaction de polymérisation en chaine en temps réel , Testicule/effets des médicaments et des substances chimiques , Testicule/métabolisme , Testostérone/sangRÉSUMÉ
This study was conducted to assess effects of aluminum (Al) exposure on allergic responsive reactions and humoral immune function in rats. Forty male Wistar rats (5 weeks old) weighed 110-120 g were randomly allocated into four groups and were orally exposed to 0, 64.18, 128.36, and 256.72 mg/kg body weight aluminum trichloride in drinking water for 120 days. The levels of immunoglobulin (Ig) G, IgA, IgM, IgE, Complement factor (C)3, and C4 in serum were determined by ELISA and nephelometric assays at the end of experiment. The results showed that the levels of IgM, C3, and C4 were lowered, and the levels of IgG, IgA, and IgE were increased in an Al-dose dependent manner. The increased in IgE level and the decreased in C3 and C4 levels indicate that Al induces allergic responses in rats; while the increased levels in IgG and IgA and the decreased level in IgM suggest that Al disorders the humoral immune function in rats.
Sujet(s)
Composés de l'aluminium/toxicité , Production d'anticorps/effets des médicaments et des substances chimiques , Production d'anticorps/immunologie , Chlorures/toxicité , Hypersensibilité/immunologie , Immunoglobulines/immunologie , Chlorure d'aluminium , Composés de l'aluminium/administration et posologie , Animaux , Chlorures/administration et posologie , Mâle , Rats , Rat WistarRÉSUMÉ
This study assessed effects of aluminum (Al) exposure on the immune function of erythrocytes in rats. Forty male Wistar rats (5 weeks old) weighed 110-120 g were randomly allocated equally into four groups according to their weights and were orally exposed to 0, 64.18, 128.36, and 256.72 mg/kg body weight aluminum trichloride in drinking water for 120 days. Levels of erythrocytes C(3b) receptor rate (RBC-C(3b)RR), erythrocytes C(3b) immune complex rosette rate (RBC-ICR), erythrocytes rosette forming enhancing rate (ERER) and erythrocytes rosette forming inhibitory rate (ERIR) were determined by the end of experiment. The three Al-treated groups had lower values of RBC-C(3b)RR and ERER, and higher values of RBC-ICR and ERIR than those in control group. The levels of RBC-C(3b)RR and ERER decreased, while the levels of RBC-ICR and ERIR increased with the increases of Al content in drinking water. The results suggest that the immune function of erythrocytes in rats is suppressed by Al exposure.
Sujet(s)
Aluminium/pharmacologie , Érythrocytes/effets des médicaments et des substances chimiques , Test des rosettes , Animaux , Poids/effets des médicaments et des substances chimiques , Érythrocytes/immunologie , Mâle , Rats , Rat WistarRÉSUMÉ
The purpose of the study was to investigate the effects of aluminum (Al) exposure on bone mineral elements, trace elements, and bone mineral density (BMD) in rats. One hundred Wistar rats were divided randomly into two groups. Experimental rats were given drinking water containing aluminum chloride (AlCl(3), 430 mg Al(3+)/L), whereas control rats were given distilled water for up to 150 days. Ten rats were sacrificed in each group every 30 days. The levels of Al, calcium (Ca), phosphorus (P), magnesium (Mg), zinc (Zn), iron (Fe), copper (Cu), manganese (Mn), selenium (Se), boron (B), and strontium (Sr) in bone and the BMD of femur were measured. Al-treated rats showed lower deposition of Ca, P, and Mg compared with control rats. Levels of trace elements (Zn, Fe, Cu, Mn, Se, B, and Sr) were significantly lower in the Al-treated group than in the control group from day 60, and the BMD of the femur metaphysis in the Al-treated group was significantly lower than in the control group on days 120 and 150. These findings indicate that long-term Al exposure reduces the levels of mineral and trace elements in bone. As a result, bone loss was induced (particularly in cancellous bone).